---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-092908"
form_type: "8-K"
ticker: "BGMS"
cik: "0001130166"
company_name: "Bio Green Med Solution, Inc."
filed_at: "2024-08-26T23:59:59+00:00"
generated_at: "2026-05-31T07:34:37.124469+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Cyclacel receives Nasdaq delisting notice due to equity noncompliance; trading may be suspended Sep 3

## Summary
- Stockholders' equity was $999K as of June 30, 2024, below Nasdaq's $2.5M minimum for continued listing.
- Nasdaq staff determined company failed to show ability to achieve or sustain compliance after prior notice in March 2024.
- Unless appeal is requested by Aug 29, 2024, trading of CYCC and CYCCP shares will be suspended at open on Sep 3, 2024.
- Management plans to request a hearing before the Nasdaq Hearings Panel, which would temporarily stay delisting.
- Previously completed an equity raise of ~$6.3M in May 2024 but still could not regain compliance.

## SEC filing metadata
- accession: 0001104659-24-092908
- form_type: 8-K
- ticker: BGMS
- cik: 0001130166
- company_name: Bio Green Med Solution, Inc.
- filed_at: 2024-08-26T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130166/000110465924092908/0001104659-24-092908-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130166/000110465924092908/tm2422661d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-092908
- JSON: https://secwatch.observer/filing/0001104659-24-092908.json
- Plain text: https://secwatch.observer/filing/0001104659-24-092908.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.